Alle verbonden artikelen

Aging and malignant hemopathies.

Auteurs : Bron D, Ades L, Fulop T, Goede V
Jaar : 2015
Journal : Haematologica
Volume : 100(5)
Pagina's : 571-4

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium.

Auteurs : Pirnay JP, Baudoux E, Cornu O, Delforge A, Delloye C, Guns J, Heinen E, Van den Abbeel E, Vanderkelen A, Van Geyt C, van Riet I, Verbeken G, De Sutter P, Verlinden M, Huys I, Cockbain J, Chabannon C, Dierickx K, Schotsmans P, De Vos D, Rose T, Jennes S, Sterckx S
Jaar : 2015
Journal : EMBO Rep.
Volume : 16(5)
Pagina's : 557-62

Aging and blood disorders: new perspectives, new challenges.

Auteurs : Bron D, Ades L, Fulop T, Goede V, Stauder R
Jaar : 2015
Journal : Haematologica
Volume : 100(4)
Pagina's : 415-7

NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cells.

Auteurs : Al Akoum C, Akl I, Rouas R, Fayyad-Kazan M, Falha L, Renno T, Burny A, Lewalle P, Fayyad-Kazan H, Badran B
Jaar : 2015
Journal : Hum Immunol
Volume : 76(5)
Pagina's : 307-17

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.

Auteurs : Muylle K, Flamen P, Vugts DJ, Guiot T, Ghanem G, Meuleman N, Bourgeois P, Vanderlinden B, van Dongen GA, Everaert H, Vaes M, Bron D
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42(8)
Pagina's : 1304-14

In honor of Professor Philippe Martiat

Auteurs : Bron D, Lewalle P
Jaar : 2015
Journal : Rev Med Brux
Volume : 36(1)
Pagina's : 58-9

Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.

Auteurs : Stamatopoulos B, Van Damme M, Crompot E, Dessars B, El Housni H, Mineur P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Mol. Med.
Volume : 21(1)
Pagina's : 123-33

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.

Auteurs : Czuczman MS, Kahanic S, Forero A, Davis G, Munteanu M, Van Den Neste E, Offner F, Bron D, Quick D, Fowler N
Jaar : 2015
Journal : Ann Hematol
Volume : 94(4)
Pagina's : 633-41

In vivo characterizatio of the BLV miRNA cluster

Auteurs : Rodari A, Van Driessche B, Delacourt N, Vanhulle C, Burny A, Van den Broeke A, Rohr O, Van Lint C
Jaar : 2015
Journal : Retrovirology
Volume : 12(1
Pagina's : 11

Circadian and circannual variations in cord blood hematopoietic cell composition.

Auteurs : Servais S, Baudoux E, Brichard B, Bron D, Debruyn C, De Hemptinne D, Deneys V, Paulus JM, Schaaps JP, Van Cauwenberge JR, Seidel L, Delforge A, Beguin Y
Jaar : 2015
Journal : Haematologica
Volume : 100(1)
Pagina's : 32-34

Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Jaar : 2015
Journal : Stem Cell Rev
Volume : 11(3)
Pagina's : 442-52

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, Meuleman N, Lagneaux L
Jaar : 2015
Journal : Cancer Immunol Immunother
Volume : 64(2)
Pagina's : 213-24

Myelofibrosis patients in Belgium: disease characteristics.

Auteurs : Devos T, Zachée P, Bron D, Noens L, Droogenbroeck JV, Mineur P, Beguin Y, Berneman Z, Benghiat FS, Kentos A, Chatelain C, Demuynck H, Lemmens J, Eygen KV, Theunissen K, Trullemans F, Pierre P, Pluymers W, Knoops L
Jaar : 2015
Journal : Acta Clin Belg
Volume : 70(2)
Pagina's : 105-11

Current management of marginal zone lymphomas.

Auteurs : Bonnet C, Lejeune M, Van Kemseke C, Bron D, Beguin Y
Jaar : 2015
Journal : Rev Med Suisse
Volume : 11
Pagina's : 1549-56

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

Auteurs : de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F
Jaar : 2015
Journal : Ann Hematol
Volume : 94
Pagina's : 1981-9

The prevalence and implications of elderly inpatients' desire for a formal psychological help at the start of cancer treatment.

Auteurs : Dubruille S, Libert Y, Merckaert I, Reynaert C, Vandenbossche S, Roos M, Bron D, Razavi D
Jaar : 2015
Journal : Psychooncology
Volume : 24(3)
Pagina's : 294-301

Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].

Auteurs : Bron D, de Wind R, Cantinieaux B, Woff E, Roelandts M, Moerman C, Lemort M, Heimann P, de Wilde V, Meuleman N, Maerevoet M
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 237-47

Multicenter implementation of geriatric assessment in Belgian patients with cancer: A survey on treating physicians' general experiences and expectations.

Auteurs : Kenis C, Heeren P, Bron D, Decoster L, Moor R, Pepersack T, Langenaeken C, Rasschaert M, Jerusalem G, Van Rijswijk R, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2014
Journal : J Geriatr Oncol
Volume : 5(4)
Pagina's : 431-8

Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.

Auteurs : Chalandon Y, Passweg JR, Guglielmi C, Iacobelli S, Apperley J, Schaap NP, Finke J, Robin M, Fedele R, Bron D, Yakoub-Agha I, van Biezen A, de Witte T, Kröger N, Olavarria E
Jaar : 2014
Journal : Haematologica
Volume : 99(9)
Pagina's : 1492-8

Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization.

Auteurs : Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, Meuleman N, Bron D, Lagneaux L
Jaar : 2014
Journal : Stem Cells Dev.
Volume : 23(19)
Pagina's : 2390-2400